Trials / NCT02280135
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Completed Phase 1 Cell therapy
- Sponsor
- Red de Terapia Celular
- Treatment
- Intravitreal injection of Autologous bone marrow Stem Cell; Subconjunctival injection of saline
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 70 Years
- Enrollment
- 8 participants
- Started
- 2014-11
- Main results expected
- 2017-03
- Results posted
- Not yet
- Record last updated
- 2017-03-30
What the study is testing
The purpose of this study is to evaluate the safety of intravitreal injection of autologous bone marrow stem cells in patients with retinitis pigmentosa by a prospective, single-center, randomized, parallel, double-blind, phase I placebo-controlled clinical trial.
Where it runs
Spain (1)
- Clinical Universitary Hospital Virgen de la Arrixaca, El Palmar, Murcia